Shenzhen Edge Medical Co., Ltd. (HKG:2675)
36.86
+2.18 (6.29%)
Sep 30, 2026, 4:08 PM HKT
Shenzhen Edge Medical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Shenzhen Edge Medical stock has a consensus rating of "Strong Buy" and an average price target of $68.40. The average 1-year stock price forecast is 85.57% higher than the current stock price, while the lowest is $51.40 (+39.45%) and the highest is $99.31 (+169.42%).
Price Target: $68.40 (+85.57%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Shenzhen Edge Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 2 | 3 | 3 | 3 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 3 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DBS | DBS | Buy Maintains $51.40 | Buy | Maintains | $51.40 | +39.45% | Sep 14, 2026 |
Unknown Analyst Huachuang Securities No rating | Huachuang Securities | Buy Maintains $74.00 | Buy | Maintains | $74.00 | +100.76% | Aug 12, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $75.00 | Buy | Maintains | $75.00 | +103.47% | Jul 3, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Initiates $81.00 | Buy | Initiates | $81.00 | +119.75% | Apr 22, 2026 |
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $73.85 | Buy | Maintains | $73.85 | +100.35% | Apr 8, 2026 |
Financial Forecast
Revenue This Year
851.50M
from 455.72M
Increased by 86.85%
Revenue Next Year
1.38B
from 851.50M
Increased by 61.89%
EPS This Year
0.20
from -0.06
EPS Next Year
0.55
from 0.20
Increased by 170.82%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.